StockData
Unicycive Therapeutics, Inc. logo

Unicycive Therapeutics, Inc. (UNCY) stock

UNCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$3.57−0.13 (-3.51%)

Close on Nov 18, 2026Market cap $99.44MP/E –Yield –

Unicycive Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Unicycive Therapeutics

Unicycive Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Unicycive Therapeutics figures

See a number that looks wrong?